Shaperon Inc is a Korea-based company mainly engaged in the biopharmaceutical business. The Company is engaged in the research, development (R&D), manufacture and sale of pneumonia therapy, alzheimer's disease therapy and atopic therapy as well as other medicines.

Employees

Sector

Biotechnology & Medical Research

Calendar

09-21 Significant Split/Dividend

More about the company

Quotes

Date	Price	Change	Volume
26-07-24	₩520.00	-1.14%	1,168,580
26-07-23	₩526.00	+0.96%	415,536
26-07-22	₩521.00	+0.58%	465,156
26-07-21	₩518.00	+0.78%	1,132,306

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. Other stock markets 2026-07-24			5-day change	1st Jan Change
520.00 ^KRW	-1.14%		-2.80%	-70.11%

07-01	Shaperon Inc. completed the acquisition of 60% stake in Needs Tech Co., Ltd.	CI
07-01	Shaperon Inc. agreed to acquire 60% stake in Needs Tech Co., Ltd. from Jeon Sang-yeon for KRW 3.7 billion.	CI

Market Cap	24.05B 16.47M 14.46M 13.45M 12.34M 23.19M 1.59B 23.55M 160M 62.4M 780M 61.81M 60.48M 2.7B	P/E 2024	-6.33x	P/E 2025	-3.62x
Enterprise Value	-152M -104K -91.57K -85.16K -78.14K -147K -10.04M -149K -1.01M -395K -4.94M -391K -383K -17.07M	EV / Sales 2024	5,107x	EV / Sales 2025	247x
Free-Float	83.79%	Yield 2024 *	-	Yield 2025	-

07-01	Shaperon Inc. completed the acquisition of 60% stake in Needs Tech Co., Ltd.	CI
07-01	Shaperon Inc. agreed to acquire 60% stake in Needs Tech Co., Ltd. from Jeon Sang-yeon for KRW 3.7 billion.	CI
04-14	Shaperon Inc. announced that it has received KRW 8.6 billion in funding	CI
04-06	Shaperon Inc. announced that it expects to receive KRW 8.6 billion in funding	CI
11-13	Shaperon Inc. Attends 7th Inflammasome Therapeutics Summit in Boston	CI
24-06-10	Shaperon and Dong-A St Sign MOU for Nanobody-Based New Drug Development	CI
24-03-18	Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel'	CI
22-10-12	Shaperon Inc. has completed an IPO in the amount of KRW 13.735 billion.	CI
22-01-06	Shaperon Inc. has filed an IPO.	CI

1 day	-1.14%
1 week	-2.80%
Current month	+2.36%
1 month	-8.45%
3 months	-71.19%
6 months	-73.71%
Current year	-70.11%

Shaperon Inc. Stock

Stocks

A378800

KR7378800007

Biotechnology & Medical Research

Valuation: Shaperon Inc.

Chart: Shaperon Inc.

Latest news : Shaperon Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Shaperon Inc.

Latest insider transactions

Bio Therapeutic Drugs

Financials

Company Profile

Quotes

Income Statement and Estimates

Manager	Title	Age	Since
Seung-Yong Sung CEO	Chief Executive Officer	61	2010-09-30
Han-Soo Kim AUD	Comptroller/Controller/Auditor	59	2019-02-28

Director	Title	Age	Since
Seung-Yong Sung BRD	Director/Board Member	61	2010-09-30
Sang-Heung Han BRD	Director/Board Member	70	2022-02-28
Chung-Yeol Seo BRD	Director/Board Member	62	2023-09-30

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SHAPERON INC.	-1.14%	-2.80%	-81.69%	-87.06%	16.47M
ARGENX SE	-0.22%	+6.45%	+56.74%	+71.01%	57.28B
WUXI APPTEC CO., LTD.	-1.92%	+6.03%	+40.64%	+80.66%	54.99B
INSMED INCORPORATED	+0.01%	-1.29%	+2.86%	+425.15%	23.18B
BIONTECH SE	+0.39%	-2.35%	-22.53%	-15.34%	22.59B
WUXI BIOLOGICS (CAYMAN) INC.	-1.13%	+1.05%	+20.81%	-7.73%	20.46B
GENMAB A/S	+0.37%	+2.00%	+25.81%	-29.96%	17.56B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-0.10%	+1.88%	+34.42%	+545.91%	15.67B
PHARMAESSENTIA CORPORATION	-1.30%	-5.02%	+170.77%	+310.94%	14.46B
EXELIXIS, INC.	+1.70%	-0.98%	+21.43%	+179.36%	13.92B
Average	-0.30%	+1.27%	+26.93%	+147.29%	24.01B
Weighted average by Cap.	-0.49%	+2.10%	+38.43%	+136.89%

	2024	2025
Net sales	17.7M 12.12K 10.65K 9.9K 9.09K 17.07K 1.17M 17.34K 118K 45.94K 574K 45.51K 44.53K 1.98M	228M 156K 137K 127K 117K 220K 15.02M 223K 1.51M 591K 7.39M 586K 573K 25.54M
Net income	-14.9B -10.21M -8.96M -8.34M -7.65M -14.37M -983M -14.59M -98.98M -38.67M -483M -38.31M -37.48M -1.67B	-15.53B -10.63M -9.34M -8.68M -7.97M -14.97M -1.02B -15.21M -103M -40.29M -503M -39.92M -39.06M -1.74B
Net Debt	-15.09B -10.33M -9.07M -8.44M -7.74M -14.55M -995M -14.77M -100M -39.15M -489M -38.79M -37.95M -1.69B	-24.2B -16.57M -14.55M -13.53M -12.42M -23.34M -1.6B -23.7M -161M -62.79M -785M -62.21M -60.86M -2.71B

1 week	466	586
1 month	466	660
Current year	466	2,135
1 year	466	3,390
3 years	466	6,420
5 years	466	11,600
10 years	466	11,600